APOL1 Renal-Risk Variants Do Not Associate With Incident Cardiovascular Disease or Mortality in the Systolic Blood Pressure Intervention Trial

INTRODUCTION: Relationships between apolipoprotein L1 gene (APOL1) renal-risk variants (RRVs) and cardiovascular disease (CVD) remain controversial. To clarify associations between APOL1 and CVD, a total of 2568 African American Systolic Blood Pressure Intervention Trial (SPRINT) participants were a...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Kidney Int Rep
Main Authors: Freedman, Barry I., Rocco, Michael V., Bates, Jeffrey T., Chonchol, Michel, Hawfield, Amret T., Lash, James P., Papademetriou, Vasilios, Sedor, John R., Servilla, Karen, Kimmel, Paul L., Wall, Barry M., Pajewski, Nicholas M.
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier 2017
Assuntos:
Clinical Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5527675/
https://ncbi.nlm.nih.gov/pubmed/28758155
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ekir.2017.03.008
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados